Menno van Lookeren Campagne
Research Subjects
Menno van Lookeren Campagne has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Kenneth J. Katschke
Department of Immunology, Genentech, Inc, South San Francisco, CA, 94080, USA
8 shared publicationsLauri Diehl
Department of Pathology, Genentech, Inc, South San Francisco, CA, 94080, USA
8 shared publicationsHongkang Xi
Department of Immunology, Genentech, Inc, South San Francisco, CA, 94080, USA
7 shared publicationsWyne P. Lee
Department of Translational Immunology, Genentech, Inc, South San Francisco, CA, 94080, USA
6 shared publications- Christian Wiesmann
Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
5 shared publications Linda Rangell
Department of Pathology, Genentech, Inc, South San Francisco, CA, 94080, USA
4 shared publications
Latest Publications
- 19 September 2018
- Published by Springer Nature in Nature Immunology
- Vol. 19 (10) , 1044-1046
Humoral immunity goes hormonal
- 19 September 2018
- Published by Springer Nature in Nature Immunology
- Vol. 19 (10) , 1044-1046
Humoral immunity goes hormonal
- Open Access
- 24 August 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 13055
Publisher Correction: Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
- 24 August 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 13055
Open AccessPublisher Correction: Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
- Open Access
- 1 June 2018
- Published by Elsevier in Seminars in Immunology
- Vol. 37 (C) , 4-11
Pathogen clearance and immune adherence “revisited”: Immuno-regulatory roles for CRIg
Rapid elimination of microbes from the bloodstream, along with the ability to mount an adaptive immune response, are essential for optimal host-defense. Kupffer cells are strategically positioned in the liver sinusoids and efficiently capture circulating microbes from the hepatic artery and portal vein, thus preventing bacterial dissemination. In vivo and in vitro studies have probed how complement receptor of the immunoglobulin superfamily (CRIg), also referred to as Z39Ig and V-set and Ig domain-containing 4 (VSIG4), acts as a critical player in pathogen recognition and clearance. While recent data suggested that CRIg may bind bacterial cell wall components directly, the single transmembrane receptor is best known for its interaction with complement C3 opsonization products on the microbial surface. On Kupffer cells, CRIg must capture opsonized microbes against the shear forces of the blood flow. In vivo work reveals how immune adherence (IA), a process in which blood platelets or erythrocytes associate with circulating bacteria, plays a critical role in regulating pathogen capture by CRIg under flow conditions. In addition to its typical innate immune functions, CRIg was shown to directly and indirectly influence adaptive immune responses. Here, we review our current understanding of the diverse roles of CRIg in pathogen elimination, anti-microbial immunity and autoimmunity. In particular, we will explore how, through selective capturing by CRIg, an important balance is achieved between the immunological and clearance functions of liver and spleen.
- 1 June 2018
- Published by Elsevier in Seminars in Immunology
- Vol. 37 (C) , 4-11
Open AccessPathogen clearance and immune adherence “revisited”: Immuno-regulatory roles for CRIg
Rapid elimination of microbes from the bloodstream, along with the ability to mount an adaptive immune response, are essential for optimal host-defense. Kupffer cells are strategically positioned in the liver sinusoids and efficiently capture circulating microbes from the hepatic artery and portal vein, thus preventing bacterial dissemination. In vivo and in vitro studies have probed how complement receptor of the immunoglobulin superfamily (CRIg), also referred to as Z39Ig and V-set and Ig domain-containing 4 (VSIG4), acts as a critical player in pathogen recognition and clearance. While recent data suggested that CRIg may bind bacterial cell wall components directly, the single transmembrane receptor is best known for its interaction with complement C3 opsonization products on the microbial surface. On Kupffer cells, CRIg must capture opsonized microbes against the shear forces of the blood flow. In vivo work reveals how immune adherence (IA), a process in which blood platelets or erythrocytes associate with circulating bacteria, plays a critical role in regulating pathogen capture by CRIg under flow conditions. In addition to its typical innate immune functions, CRIg was shown to directly and indirectly influence adaptive immune responses. Here, we review our current understanding of the diverse roles of CRIg in pathogen elimination, anti-microbial immunity and autoimmunity. In particular, we will explore how, through selective capturing by CRIg, an important balance is achieved between the immunological and clearance functions of liver and spleen.
- Open Access
- 9 May 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 7348
Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
Geographic atrophy (GA), the advanced form of dry age-related macular degeneration (AMD), is characterized by progressive loss of retinal pigment epithelium cells and photoreceptors in the setting of characteristic extracellular deposits and remains a serious unmet medical need. While genetic predisposition to AMD is dominated by polymorphisms in complement genes, it remains unclear how complement activation contributes to retinal atrophy. Here we demonstrate that complement is activated on photoreceptor outer segments (POS) in the retina peripheral to atrophic lesions associated with GA. When exposed to human serum following outer blood-retinal barrier breakdown, POS act as potent activators of the classical and alternative complement pathway. In mouse models of retinal degeneration, classical and alternative pathway complement activation on photoreceptors contributed to the loss of photoreceptor function. This was dependent on C5a-mediated recruitment of peripheral blood monocytes but independent of resident microglia. Genetic or pharmacologic inhibition of both classical and alternative complement C3 and C5 convertases was required to reduce progressive degeneration of photoreceptor rods and cones. Our study implicates systemic classical and alternative complement proteins and peripheral blood monocytes as critical effectors of localized retinal degeneration with potential relevance for the contribution of complement activation to GA.
- 9 May 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 7348
Open AccessClassical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
Geographic atrophy (GA), the advanced form of dry age-related macular degeneration (AMD), is characterized by progressive loss of retinal pigment epithelium cells and photoreceptors in the setting of characteristic extracellular deposits and remains a serious unmet medical need. While genetic predisposition to AMD is dominated by polymorphisms in complement genes, it remains unclear how complement activation contributes to retinal atrophy. Here we demonstrate that complement is activated on photoreceptor outer segments (POS) in the retina peripheral to atrophic lesions associated with GA. When exposed to human serum following outer blood-retinal barrier breakdown, POS act as potent activators of the classical and alternative complement pathway. In mouse models of retinal degeneration, classical and alternative pathway complement activation on photoreceptors contributed to the loss of photoreceptor function. This was dependent on C5a-mediated recruitment of peripheral blood monocytes but independent of resident microglia. Genetic or pharmacologic inhibition of both classical and alternative complement C3 and C5 convertases was required to reduce progressive degeneration of photoreceptor rods and cones. Our study implicates systemic classical and alternative complement proteins and peripheral blood monocytes as critical effectors of localized retinal degeneration with potential relevance for the contribution of complement activation to GA.
- Open Access
- 1 June 2016
- Published by Elsevier in Immunobiology
- Vol. 221 (6) , 733-739
Age-related macular degeneration: Complement in action
- 1 June 2016
- Published by Elsevier in Immunobiology
- Vol. 221 (6) , 733-739
Open AccessAge-related macular degeneration: Complement in action
- Open Access
- 11 January 2016
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 213 (2) , 189-207
IL-33 amplifies an innate immune response in the degenerating retina
Age-related macular degeneration (AMD), a leading cause of vision impairment in the ageing population, is characterized by irreversible loss of retinal pigment epithelial (RPE) cells and photoreceptors and can be associated with choroidal neovascularization. Mononuclear phagocytes are often present in AMD lesions, but the processes that direct myeloid cell recruitment remain unclear. Here, we identify IL-33 as a key regulator of inflammation and photoreceptor degeneration after retina stress or injury. IL-33+ Müller cells were more abundant and IL-33 cytokine was elevated in advanced AMD cases compared with age-matched controls with no AMD. In rodents, retina stress resulted in release of bioactive IL-33 that in turn increased inflammatory chemokine and cytokine expression in activated Müller cells. Deletion of ST2, the IL-33 receptor α chain, or treatment with a soluble IL-33 decoy receptor significantly reduced release of inflammatory mediators from Müller cells, inhibited accumulation of mononuclear phagocytes in the outer retina, and protected photoreceptor rods and cones after a retina insult. This study demonstrates a central role for IL-33 in regulating mononuclear phagocyte recruitment to the photoreceptor layer and positions IL-33 signaling as a potential therapeutic target in macular degenerative diseases.
- 11 January 2016
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 213 (2) , 189-207
Open AccessIL-33 amplifies an innate immune response in the degenerating retina
Age-related macular degeneration (AMD), a leading cause of vision impairment in the ageing population, is characterized by irreversible loss of retinal pigment epithelial (RPE) cells and photoreceptors and can be associated with choroidal neovascularization. Mononuclear phagocytes are often present in AMD lesions, but the processes that direct myeloid cell recruitment remain unclear. Here, we identify IL-33 as a key regulator of inflammation and photoreceptor degeneration after retina stress or injury. IL-33+ Müller cells were more abundant and IL-33 cytokine was elevated in advanced AMD cases compared with age-matched controls with no AMD. In rodents, retina stress resulted in release of bioactive IL-33 that in turn increased inflammatory chemokine and cytokine expression in activated Müller cells. Deletion of ST2, the IL-33 receptor α chain, or treatment with a soluble IL-33 decoy receptor significantly reduced release of inflammatory mediators from Müller cells, inhibited accumulation of mononuclear phagocytes in the outer retina, and protected photoreceptor rods and cones after a retina insult. This study demonstrates a central role for IL-33 in regulating mononuclear phagocyte recruitment to the photoreceptor layer and positions IL-33 signaling as a potential therapeutic target in macular degenerative diseases.
- Open Access
- 17 September 2014
- Published by Taylor & Francis in Cell Cycle
- Vol. 13 (18) , 2803-4
Understanding Crohn's disease through genetics.
- 17 September 2014
- Published by Taylor & Francis in Cell Cycle
- Vol. 13 (18) , 2803-4
Open AccessUnderstanding Crohn's disease through genetics.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Mo1820 IL-1β Induces Expression of Fibrosis Associated Genes in Human Primary Intestinal Myofibroblasts
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Mo1820 IL-1β Induces Expression of Fibrosis Associated Genes in Human Primary Intestinal Myofibroblasts
- Open Access
- 1 February 2013
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 93 (2) , 301-306
CRIg mediates early Kupffer cell responses to adenovirus
Journal of Leukocyte Biology considers manuscripts of original investigations focusing on the origins, developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes, and other cells involved in host defense. These include full-length papers on original research, rapid communications of new discoveries, letters, commentaries, and invited reviews.
- 1 February 2013
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 93 (2) , 301-306
Open AccessCRIg mediates early Kupffer cell responses to adenovirus
Journal of Leukocyte Biology considers manuscripts of original investigations focusing on the origins, developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes, and other cells involved in host defense. These include full-length papers on original research, rapid communications of new discoveries, letters, commentaries, and invited reviews.
- 1 September 2012
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 53 (10) , 6628-6637
Activation of the Alternative Complement Pathway in Vitreous is Controlled by Genetics in Age-Related Macular Degeneration
Purpose.: To determine if the progression of age-related macular degeneration (AMD) is associated with complement activation in the eye. Methods.: Immunohistochemistry and ELISAs were used to determine the distribution, concentration, and activation of the alternative pathway complement proteases factor B (FB) and factor D (FD) and the central complement protein C3 in genotyped human postmortem donor eyes graded as having no or minimal drusen (category 1; controls), large drusen (category 3), and large drusen with advanced AMD (category 4). Results.: C3, FB, and FD were present in vitreous and Bruch's membrane choroid (BM/C) interface of the macula of eyes in all tested AMD severity categories (n = 100). C3, FB, and FD were predominantly located to the choroidal vasculature and Bruch's membrane and, together with the serum proteins transferrin and albumin, elevated in BM/C extracts of category 4 eyes (n = 23) compared with category 1 eyes (n = 24). A significant increase in FB activation was found only in vitreous of category 4 eyes (n = 23) compared with category 1 eyes (n = 25). Genetic variants of complement factor H (CFH), C3, C2, and FB associated with increased risk of AMD were correlated with alternative pathway complement activation in vitreous, but not with complement proteins in BM/C protein extracts Conclusions.: Increased activation of the alternative complement pathway in vitreous was controlled by disease stage and genetic variation in the complement pathway, supporting a role for complement activation in AMD disease pathogenesis.
- 1 September 2012
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 53 (10) , 6628-6637
Activation of the Alternative Complement Pathway in Vitreous is Controlled by Genetics in Age-Related Macular Degeneration
Purpose.: To determine if the progression of age-related macular degeneration (AMD) is associated with complement activation in the eye. Methods.: Immunohistochemistry and ELISAs were used to determine the distribution, concentration, and activation of the alternative pathway complement proteases factor B (FB) and factor D (FD) and the central complement protein C3 in genotyped human postmortem donor eyes graded as having no or minimal drusen (category 1; controls), large drusen (category 3), and large drusen with advanced AMD (category 4). Results.: C3, FB, and FD were present in vitreous and Bruch's membrane choroid (BM/C) interface of the macula of eyes in all tested AMD severity categories (n = 100). C3, FB, and FD were predominantly located to the choroidal vasculature and Bruch's membrane and, together with the serum proteins transferrin and albumin, elevated in BM/C extracts of category 4 eyes (n = 23) compared with category 1 eyes (n = 24). A significant increase in FB activation was found only in vitreous of category 4 eyes (n = 23) compared with category 1 eyes (n = 25). Genetic variants of complement factor H (CFH), C3, C2, and FB associated with increased risk of AMD were correlated with alternative pathway complement activation in vitreous, but not with complement proteins in BM/C protein extracts Conclusions.: Increased activation of the alternative complement pathway in vitreous was controlled by disease stage and genetic variation in the complement pathway, supporting a role for complement activation in AMD disease pathogenesis.